These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 17126396)

  • 21. Coronary stents: a materials perspective.
    Mani G; Feldman MD; Patel D; Agrawal CM
    Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological effects of drug-eluting stents in the coronary circulation.
    Steffel J; Tanner FC
    Herz; 2007 Jun; 32(4):268-73. PubMed ID: 17607532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomimicry 1: PC.
    Cumberland DC; Gunn J; Malik N; Holt CM
    Semin Interv Cardiol; 1998; 3(3-4):149-50. PubMed ID: 10406685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angioscopic findings after drug-eluting stent implantation.
    Takano M; Mizuno K
    Herz; 2007 Jun; 32(4):281-6. PubMed ID: 17607534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
    Young JJ
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath.
    Desai M; Mirzay-Razzaz J; von Delft D; Sarkar S; Hamilton G; Seifalian AM
    Vasc Med; 2010 Aug; 15(4):287-97. PubMed ID: 20511293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stent coatings and local drug delivery; state of the art.
    Gunn J; Cumberland D
    Eur Heart J; 1999 Dec; 20(23):1693-700. PubMed ID: 10562476
    [No Abstract]   [Full Text] [Related]  

  • 29. New drug-eluting stent platforms to prevent stent thrombosis.
    Kereiakes DJ
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S34-43. PubMed ID: 17401310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coated stents: local pharmacology.
    Raman VK; Edelman ER
    Semin Interv Cardiol; 1998; 3(3-4):133-7. PubMed ID: 10406682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives on antisense therapy for the prevention of restenosis.
    Kipshidze N; Moses J; Shankar LR; Leon M
    Curr Opin Mol Ther; 2001 Jun; 3(3):265-77. PubMed ID: 11497351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting stents.
    Woods TC; Marks AR
    Annu Rev Med; 2004; 55():169-78. PubMed ID: 14746515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction to intravascular stents.
    Schatz RA
    Cardiol Clin; 1988 Aug; 6(3):357-72. PubMed ID: 3073006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting bioresorbable stents for various applications.
    Zilberman M; Eberhart RC
    Annu Rev Biomed Eng; 2006; 8():153-80. PubMed ID: 16834554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of catheter- and stent-based gene therapy.
    Sharif F; Daly K; Crowley J; O'Brien T
    Cardiovasc Res; 2004 Nov; 64(2):208-16. PubMed ID: 15485679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vascular stents: Approaches used to increase their clinical efficacy].
    Kuznetsov KA; Khar'kova MV; Karpenko AA; Laktionov PP
    Angiol Sosud Khir; 2018; 24(2):69-79. PubMed ID: 29924777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endovascular manipulation to restrict restenosis.
    Gershlick AH
    Vasc Med; 1998; 3(3):177-88. PubMed ID: 9892510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.
    Chan KH; Armstrong J; Withers S; Malik N; Cumberland DC; Gunn J; Holt CM
    Biomaterials; 2007 Feb; 28(6):1218-24. PubMed ID: 17126396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmable elution profile coating for drug eluting stents.
    Al-Lamee K
    Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylcholine-coated stents.
    Lewis AL; Stratford PW
    J Long Term Eff Med Implants; 2002; 12(4):231-50. PubMed ID: 12627785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.